Abstract
During the past three decades since the declaration of a war on cancer with the National Cancer Act of 1971, we have been exposed to a very public display of both the challenges and triumphs in this war. As a young medical oncologist, I anxiously awaited each annual meeting of the American Society of Clinical Oncology (ASCO), expecting to hear the latest small advances in the treatment of leukemia, lymphoma, Hodgkin’s disease, and then breast cancer (the first solid tumor that seemed to respond to multiagent chemotherapy), gradually seeing plateaus in the survival curves suggesting cure. With the phase II trials of cisplatinum, there were rumors of young men with advanced testicular cancer rising from their deathbeds after a single course of treatment. Soon thereafter, the Einhorn regimen1 of vinblastine, bleomycin and cisplatin, brought about high cure rates in this rare but devastating cancer of young men. And of course, three decades later we all know the story of Lance Armstrong, one of the world’s most famous testicular cancer survivors. However, as the breast cancer activists reminded us in the early 1990s, there were still more American women dying each year from breast cancer than U.S. deaths during the entire Vietnam War.2*
Forty-four thousand women were dying each year from breast cancer. While subsequent estimates of death in Vietnam were 759,000, breast cancer activists often used this for a point (Patricia A. Ganz, personal recollection).
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Cancer Survivor
- Clin Oncol
- Breast Cancer Survivor
- Childhood Cancer Survivor
- Childhood Acute Lymphoblastic Leukemia
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Einhorn LH, Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977;87:293–298.
Stabiner K. To Dance with the Devil: The New War on Breast Cancer; Politics, Power, People. Delacorte Press, New York, 1997.
Cancer survivorship-United States, 1971–2001. MMWR Morb Mortal Wkly Rep 2004;53:526–529.
Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 2004;101:3–27.
http://cancercontrol.cancer.gov/ocs/prevalence/prevalence.html, accessed September 26, 2006.
Balsom WR, Bleyer WA, Robison LL, et al. Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Children’s Cancer Study Group study. Med Pediatr Oncol 1991; 19:486–492.
Bhatia S, Meadows AT, Robison LL. Second cancers after pediatric Hodgkin’s disease. J Clin Oncol 1998;16:2570–2572.
Haupt R, Fears TR, Robison LL, et al. Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. JAMA 1994;272:1427–1432.
Meadows AT, Hobbie WL. The medical consequences of cure. Cancer 1986;58:524–528.
Sklar CA, Mertens AC, Walter A, et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol 2000;35:91–95.
Gotay CC, Muraoka MY. Quality of life in long-term survivors of adult-onset cancers. J Natl Cancer Inst 1998;90:656–667.
Bower JE, Ganz PA, Desmond KA, et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000;18:743–753.
Ganz PA, Rowland JH, Desmond K, et al. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol 1998;16:501–514.
Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129–135.
Schag CA, Ganz PA, Wing DS, et al. Quality of life in adult survivors of lung, colon and prostate cancer. Qual Life Res 1994;3:127–141.
Schover LR, von Eschenbach AC, Smith DB, et al. Sexual rehabilitation of urologic cancer patients: a practical approach. CA Cancer J Clin 1984;34:66–74.
Bloom JR, Fobair P, Gritz E, et al. Psychosocial outcomes of cancer: a comparative analysis of Hodgkin’s disease and testicular cancer. J Clin Oncol 1993;11:979–988.
Fobair P, Hoppe RT, Bloom J, et al. Psychosocial problems among survivors of Hodgkin’s disease. J Clin Oncol 1986;4:805–814.
Ganz PA, Desmond KA, Leedham B, et al. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 2002;94:39–49.
Hewitt M, Weiner SL, Simone JV (eds). Childhood Cancer Survivorship: Improving Care and Quality of Life. Washington, DC: National Academies Press, 2003.
Hewitt M, Greenfield S, Stovall E (eds). From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: National Academies Press, 2006.
Earle CC, Burstein HJ, Winer EP, et al. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol 2003;21:1447–1451.
Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer 2004;101:1712–1719.
Lafata JE, Simpkins J, Schultz L, et al. Routine surveillance care after cancer treatment with curative intent. Med Care 2005;43:592–599.
Lash TL, Silliman RA. Medical surveillance after breast cancer diagnosis. Med Care 2001;39:945–955.
Lehmann JF, DeLisa JA, Warren CG, et al. Cancer rehabilitation: assessment of need, development, and evaluation of a model of care. Arch Phys Med Rehabil 1978;59:410–419.
DeLisa JA. A history of cancer rehabilitation. Cancer 2001;92:970–974.
Harvey RF, Jellinek HM, Habeck RV. Cancer rehabilitation. An analysis of 36 program approaches. JAMA 1982;247:2127–2131.
Gerber LH. Cancer rehabilitation into the future. Cancer 2001; 92:975–979.
Schover LR, Brey K, Lichtin A, et al. Oncologists’ attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol 2002;20:1890–1897.
Schover LR, Brey K, Lichtin A, et al. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol 2002;20:1880–1889.
Ganz PA. ASCO Cancer Prevention Survey. 2005.
Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol 2005;23:276–292.
Narod SA, Offit K. Prevention and management of hereditary breast cancer. J Clin Oncol 2005;23:1656–1663.
Mullan F. Seasons of survival: reflections of a physician with cancer. N Engl J Med 1985;313:270–273.
Kazak AE, Barakat LP, Meeske K, et al. Posttraumatic stress, family functioning, and social support in survivors of childhood leukemia and their mothers and fathers. J Consult Clin Psychol 1997;65:120–129.
Kazak AE, Stuber ML, Barakat LP, et al. Predicting posttraumatic stress symptoms in mothers and fathers of survivors of childhood cancers. J Am Acad Child Adolesc Psychiatry 1998;37:823–831.
Demark-Wahnefried W, Aziz N, Rowland JH, et al. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005;23:5814–5830.
Ganz PA. A teachable moment for oncologists: cancer survivors, 10 million strong and growing! J Clin Oncol 2005;23:5458–5460.
Rapp SR, Espeland MA, Shumaker SA, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: The Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2663.
Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651.
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–333.
Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;10.1056/NEJMoa030311.
Holmberg PL, Anderson H. HABITS (hormonal replacement therapy after breast cancer—is it safe?), a randomised comparison: trial stopped. The Lancet 2004;363:453–455.
Lippman SM, Levin B. Cancer prevention: strong science and real medicine. J Clin Oncol 2005;23:249–253.
Hong WK, Spitz MR, Lippman SM. Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets. J Clin Oncol 2000;18:9s–18.
Lippman SM, Brown PH. Tamoxifen prevention of breast cancer: an instance of the fingerpost. JNCI Cancer Spectrum 1999;91:1809–1819.
Cuzick J. Aromatase inhibitors for breast cancer prevention. J Clin Oncol 2005;23:1636–1643.
Fabian CJ, Kimler BF. Selective estrogen-receptor modulators for primary prevention of breast cancer. J Clin Oncol 2005;23:1644–1655.
Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003;348:883–890.
Yeazel MW, Oeffinger KC, Gurney JG, et al. The cancer screening practices of adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 2004;100:631–640.
Emmons K, Li FP, Whitton J, et al. Predictors of smoking initiation and cessation among childhood cancer survivors: A report from the Childhood Cancer Survivor Study. J Clin Oncol 2002; 20:1608–1616.
Emmons KM, Butterfield RM, Puleo E, et al. Smoking among participants in the childhood cancer survivors cohort: the partnership for health study. J Clin Oncol 2003;21:189–196.
Kenney LB, Yasui Y, Inskip PD, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 2004;141:590–597.
Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children’s Oncology Group Long-Term Follow-Up Guidelines from the Children’s Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 2004;JCO.
Ganz PA. Current issues in cancer rehabilitation. Cancer 1990; 65:742–751.
Ganz PA. The status of cancer rehabilitation in the late 1990s. Mayo Clin Proc 1999;74:939–940.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Ganz, P.A. (2007). Cancer Survivors: A Physician’s Perspective. In: Ganz, P.A. (eds) Cancer Survivorship. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68265-5_1
Download citation
DOI: https://doi.org/10.1007/978-0-387-68265-5_1
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-34349-5
Online ISBN: 978-0-387-68265-5
eBook Packages: MedicineMedicine (R0)